Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 1, 2014, Pages 95-105

  Gualdoni, Guido A ^a   Kovarik, Johannes J ^b   Hofer, Johannes ^a   Dose, Franziska ^b   Doberer, Daniel ^b   Steinberger, Peter ^a   Wolzt, Michael ^b   Zlabinger, Gerhard J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Immunomodulation; Monocyte; Resveratrol; Signaling; Toll like receptor; Tumor necrosis factor

Indexed keywords

DRUG METABOLITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; PROTEIN P105; RESVERATROL; RESVERATROL 3 O DEXTRO GLUCURONIDE; RESVERATROL 3 O SULFATE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; UPREGULATION; WESTERN BLOTTING;

ANIMALIA; BACTERIA (MICROORGANISMS);

FLA; FLAGELLIN; GAPDH; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IL; IMMUNOMODULATION; INTERLEUKIN; LIPOLYSACCHARIDE; LPS; MAPK; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE; NF-ΚB; NUCLEAR FACTOR 'KAPPA-LIGHT-CHAIN-ENHANCER' OF ACTIVATED B-CELLS; PBMC; PBS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHOSPHATE BUFFERED SALINE; RESVERATROL; SAC; SIGNALING; STAPHYLOCOCCUS AUREUS CELLS; TNF-Α; TOLL-LIKE RECEPTOR; TUMOR NECROSIS FACTOR-Α;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HEALTHY VOLUNTEERS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PILOT PROJECTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84885008835     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.09.009     Document Type: Article

References (37)

1. M. Shakibaei, K.B. Harikumar, and B.B. Aggarwal Resveratrol addiction: to die or not to die Mol. Nutr. Food Res. 53 2009 115 128
2. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220 (Pubitemid 127696281)
3. A. Bishayee Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials Cancer Prev. Res. (Phila.) 2 2009 409 418
4. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and D. Sinclair Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689 (Pubitemid 39061685)
5. M. Frombaum, S. Le Clanche, D. Bonnefont-Rousselot, and D. Borderie Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and*NO bioavailability: potential benefits to cardiovascular diseases Biochimie 94 2012 269 276
6. J.-G. Lee, J.-M. Yon, C. Lin, A.Y. Jung, K.Y. Jung, and S.-Y. Nam Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons Food Chem. Toxicol. 50 2012 3877 3885
7. B. Gonthier, N. Allibe, C. Cottet-Rousselle, F. Lamarche, L. Nuiry, and L. Barret Specific conditions for resveratrol neuroprotection against ethanol-induced toxicity J. Toxicol. 2012 2012 973134
8. V. Vingtdeux, L. Giliberto, H. Zhao, P. Chandakkar, Q. Wu, J.E. Simon, E.M. Janle, J. Lobo, M.G. Ferruzzi, P. Davies, and P. Marambaud AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism J. Biol. Chem. 285 2010 9100 9113
9. J.-K. Jeong, M.-H. Moon, B.-C. Bae, Y.-J. Lee, J.-W. Seol, H.-S. Kang, J.-S. Kim, S.-J. Kang, and S.-Y. Park Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity Neurosci. Res. 73 2012 99 105
10. T.J. Imler Jr., and T.M. Petro Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17 + IL-10 + T cells, CD4(-) IFN-gamma + cells, and decreased macrophage IL-6 expression Int. Immunopharmacol. 9 2009 134 143
11. S. Bereswill, M. Muñoz, A. Fischer, R. Plickert, L.-M. Haag, B. Otto, A.A. Kühl, C. Loddenkemper, U.B. Göbel, and M.M. Heimesaat Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation PLoS One 5 2010 e15099
12. K. Rahal, P. Schmiedlin-Ren, J. Adler, M. Dhanani, V. Sultani, A.C. Rittershaus, L. Reingold, J. Zhu, B.J. McKenna, G.M. Christman, and E.M. Zimmermann Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease Inflamm. Bowel Dis. 18 2012 613 623
13. A. Bishayee, A. Waghray, K.F. Barnes, T. Mbimba, D. Bhatia, M. Chatterjee, and A.S. Darvesh Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis Pharm. Res. 27 2010 1080 1091
14. A. Bishayee, K.F. Barnes, D. Bhatia, A.S. Darvesh, and R.T. Carroll Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis Cancer Prev. Res. (Phila.) 3 2010 753 763
15. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health - a comprehensive review of human clinical trials Mol. Nutr. Food Res. 55 2011 1129 1141
16. O. Vang, N. Ahmad, C.A. Baile, J.A. Baur, K. Brown, A. Csiszar, D.K. Das, D. Delmas, C. Gottfried, H.-Y. Lin, Q.-Y. Ma, P. Mukhopadhyay, N. Nalini, J.M. Pezzuto, T. Richard, Y. Shukla, Y.-J. Surh, T. Szekeres, T. Szkudelski, and T. Walle What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLoS One 6 2011 e19881
17. L.-M. Zhong, Y. Zong, L. Sun, J.-Z. Guo, W. Zhang, Y. He, R. Song, W.-M. Wang, C.-J. Xiao, and D. Lu Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells PLoS One 7 2012 e32195
18. M.A. Panaro, V. Carofiglio, A. Acquafredda, P. Cavallo, and A. Cianciulli Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells Br. J. Nutr. 2012 1 10
19. Y. Zong, L. Sun, B. Liu, Y.-S. Deng, D. Zhan, Y.-L. Chen, Y. He, J. Liu, Z.-J. Zhang, J. Sun, and D. Lu Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 2647 macrophage cells PLoS One 7 2012 e44107
20. T. Mbimba, P. Awale, D. Bhatia, W.J. Geldenhuys, A.S. Darvesh, R.T. Carroll, and A. Bishayee Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis Curr. Pharm. Biotechnol. 13 2012 229 234
21. D.J. Boocock, G.E.S. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, M.P. Ducharme, T.D. Booth, J.A. Crowell, M. Perloff, A.J. Gescher, W.P. Steward, and D.E. Brenner Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev. 16 2007 1246 1252 (Pubitemid 46984966)
22. J.J. Kovarik, W. Tillinger, J. Hofer, M.A. Hölzl, H. Heinzl, M.D. Saemann, and G.J. Zlabinger Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD Eur. J. Clin. Invest. 41 2011 291 298
23. A. Jörgl, B. Platzer, S. Taschner, L.X. Heinz, B. Höcher, P.M. Reisner, F. Göbel, and H. Strobl Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB Blood 109 2007 185 193 (Pubitemid 46053060)
24. J. Leitner, K. Grabmeier-Pfistershammer, O. Majdic, G. Zlabinger, and P. Steinberger Interaction of antithymocyte globulins with dendritic cell antigens Am. J. Transplant. 11 2011 138 145
25. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
26. C.-H. Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, and J.-L. Beaudeux Resveratrol bioavailability and toxicity in humans Mol. Nutr. Food Res. 54 2010 7 16
27. H. Liu, P. Sidiropoulos, G. Song, L.J. Pagliari, M.J. Birrer, B. Stein, J. Anrather, and R.M. Pope TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta J. Immunol. 164 2000 4277 4285 (Pubitemid 30215089)
28. H. Ghanim, C.L. Sia, S. Abuaysheh, K. Korzeniewski, P. Patnaik, A. Marumganti, A. Chaudhuri, and P. Dandona An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol J. Clin. Endocrinol. Metab. 95 2010 E1 E8
29. H. Ghanim, C.L. Sia, K. Korzeniewski, T. Lohano, S. Abuaysheh, A. Marumganti, A. Chaudhuri, and P. Dandona A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal J. Clin. Endocrinol. Metab. 96 2011 1409 1414
30. Y.-C. Oh, O.-H. Kang, J.-G. Choi, H.-S. Chae, Y.-S. Lee, O.-O. Brice, H.J. Jung, S.-H. Hong, Y.-M. Lee, and D.-Y. Kwon Anti-inflammatory effect of resveratrol by inhibition of IL-8 production in LPS-induced THP-1 cells Am. J. Chin. Med. 37 2009 1203 1214
31. V.O. Shah, J.E. Ferguson, L.A. Hunsaker, L.M. Deck, and D.L. Vander Jagt Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells Nat. Prod. Res. 24 2010 1177 1188
32. P. Boscolo, A. del Signore, E. Sabbioni, M. Di Gioacchino, L. Di Giampaolo, M. Reale, P. Conti, R. Paganelli, and M. Giaccio Effects of resveratrol on lymphocyte proliferation and cytokine release Ann. Clin. Lab. Sci. 33 2003 226 231 (Pubitemid 36705934)
33. R. Falchetti, M.P. Fuggetta, G. Lanzilli, M. Tricarico, and G. Ravagnan Effects of resveratrol on human immune cell function Life Sci. 70 2001 81 96 (Pubitemid 33124357)
34. A. Bishayee, and N. Dhir Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis Chem. Biol. Interact. 179 2009 131 144
35. A.K. Moorthy, O.V. Savinova, J.Q. Ho, V.Y.-F. Wang, D. Vu, and G. Ghosh The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation- independent manner EMBO J. 25 2006 1945 1956
36. N.C. Whitlock, and S.J. Baek The anticancer effects of resveratrol: modulation of transcription factors Nutr. Cancer 64 2012 493 502
37. H. Capiralla, V. Vingtdeux, H. Zhao, R. Sankowski, Y. Al-Abed, P. Davies, and P. Marambaud Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade J. Neurochem. 120 2012 461 472